multiple copies (alleles) of the ribosomal operon in their genome increases the possibility that a substantial amount of sequence variation exists in these spacer regions, even among strains of the same species. This diversity represents a powerful tool for the design of specific oligonucleotides for polymerase chain reaction (PCR)-based detection protocols. [2] 
Introduction
In bacteria, 16S and 23S ribosomal ribonucleic acid (rRNA) genes are separated by a spacer region, which is transcribed collectively with the ribosomal genes and therefore is called an internal transcribed spacer(s) (ITS). These genomic regions show a high degree of variability between species, both in their base length and in their sequence. [1] The fact that most bacterial species harbor
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as well as its close relatives, belonging to genomic species 3 ("Acinetobacter pittii") and 13TU ("Acinetobacter nosocomialis"), from what is called the "A. baumannii complex". These are the three species of the most clinical importance, causing a vast majority of Acinetobacter infections, but they cannot be differentiated by routine diagnostic tests. [10] The members of the complex are very difficult to separate reliably by phenotypic methods alone and frequently are placed into groups or complexes based on biochemical test results. The goal of the present study was to evaluate the use of PCR analysis of 16S-23S rRNA ITS in the identification of the Acinetobacter among patients.
Materials and Methods

Samples collection
All patients admitted to Assir Central Hospitals General Lab with infections proved to be caused by Acinetobacter spp. by bacteriological investigations were selected during the study period December 2011-2013. A total of 100 patients were involved in this study, including both sexes and ages (children and adults) with variable nosocomial infections. Nosocomial infections may be defined as any systemic or localized conditions that result from the response by an infectious agent or toxin. [11] Traditionally, a cut-off of 48 h after admission is used to differentiate between hospital and community acquired infections. [12] Yet, this cut-off point does not present the patients' carrier status that can cause the infection. To overcome this problem, a classification based on pathogenesis of infection and the criteria for carrier status were offered. [13] Nosocomial infection include; respiratory tract infections, urinary tract infections, blood stream septicemia and skin sepsis. Aseptic precautions and measures were applied using cleaning with antiseptic of the margins of swab area, wearing gloves and uses of sterile swabs nevertheless no mixed infections were encountered in our samples. The laboratory specimens include; skin and nasal swabs (collected from the nares with a dry (stainless steel), un-moistened swab, a tip of the collection swab was inserted approximately 2.56 cm into the nares and rolled five times in each nostril), urine (mid-stream urine, 20 ml) and blood (venous blood 5 ml). Collected specimens were transported and stored at room temperature. Clinical data, including the inpatient and out-patient categories, antibiotics usage and patient's history of diabetes was registered. Each sample was examined using all bacteriological tests including, gram staining characteristics, fermentation test, catalase and antibiotic sensitivity test. Each sample was cultured in two media (Blood agar and MacConkey agar) for 24 h. Positive Acinetobacter isolates were cultured on nutrient agar plates for molecular analysis. Following the incubation, bacterial colonies were picked with sterile wooden toothpicks, suspended in sterile Milli-Q and boiled for 5 min. The suspension was then centrifuged at 12,000 rpm for 10 min and the resulting supernatant containing the bacterial deoxyribonucleic acid (DNA) (50 ng) was used as a template for the polymerase chain reaction (PCR) amplification.
Amplification of ITS region and nucleotide sequence determination
PCR amplification of 16S-23S intergenic spacer sequences (ITS) was performed using the bacterium-specific universal primers 1512F 5`GTCGTAACAAGGTAGCCGTA3` and 6R 5`GGGTTCCCCCRTTCAGAAAT3` (Gene Link Inc., NY, USA). The amplified DNA fragment covered a small fragment of the 16S rRNA gene region, the ITS and a small fragment of the 23S rRNA gene region. The 5′ end of primer 1512F is located at position 1493 of the 16S rRNA gene and the 5′ end of primer 6R is located at position 108 downstream of the 5′ end of the 23S rRNA gene. PCR was performed with 5 μl (5 ng) of template DNA (Acinetobacter isolates and Escherichia coli as control) in a total reaction volume of 25 μl consisting of PCR reaction buffer (10 mM Tris-HCl (pH 8.8), 50 mM KCl, 1.5 mM MgCl 2 ), 0.8 mM deoxyribonucleoside triphosphates (0.2 mM each), 10 pmol of each primer, and 1 U of Taq DNA polymerase (Qiagen, USA). The PCR program consisted of the following cycles: Initial denaturation at 95°C for 3 min, and 30 cycles of denaturation at 95°C for 1 min, annealing at 55°C for 1 min, extension at 72°C for 1 min and a final extension at 72°C for 5 min using MWG-Biotech Primus 96 Plus Thermal Cycler. The products were visualized in 1% of agarose gel electrophoresis and their sizes were estimated by comparison with a 100 bp DNA ladder (Invitrogen, San Diego, CA). The PCR product was sequenced by Macrogen Inc., (Seoul, Korea). Sequence results from PCR product was aligned and assembled to obtain a complete 16S rRNA consensus. ITS DNA sequences of the isolates along with sequences of known Acinetobacter genospecies prototype strains retrieved from the GeneBank were aligned using were aligned by using molecular evolutionary genetic analysis programs (Mega 5.10), and manually optimized using GeneDoc (version 2.7). Phylogenetic tree was constructed using the neighbor-joining algorithm, and the resulting tree was displayed using MEGA5.
GeneBank number
ITS sequence data examined in this study was deposited with GeneBank. Accession number is KC237879.1.
Results
The 16S-23S ITS fragments of clinical isolates were amplified by PCR with primers 1512F and 6R. A single amplicon was observed with an approximate size of 786 bp [ Figure 1 ]. The following sequencing analysis confirmed the identification of A. baumannii. The BLAST program in National Center for Biotechnology Information was used to align the 16S-23S rRNA intergenic spacer sequence of the new isolates with previously published sequences in the public database. ITS sequence analysis showed that there was a strong similarity between the isolates and representative strains of the genus Acinetobacter in gene bank [ Figure 2 ], indicating that 16S-23S rRNA intergenic spacer sequence data is helpful for bacterial identification. There was only four nucleotide difference of the 16S-23S ITS sequence between our isolates and A. baumannii ATCC 19606. The percentage of match to GenBank sequence U60279 (A. baumannii), U60280 (Acinetobacter ATCC19004, genomospecies 3), U60281 (Acinetobacter ATCC17903, genomospecies 13), and U60278 (Acinetobacter calcoaceticus, genomospecies 1) was 99.0%, 99.0%, 95.0%, and 92.0%, respectively [ Figure 3 ].
Discussion
The high incidence of nosocomial infections is a vital problem on individual patients as well as on the health care system as observed by an increased morbidity including delayed wound healing, increased exposure to antimicrobial therapy and its possible antagonistic effects, and prolonged hospitalization. [14] Over the past two decades, Acinetobacter species has been associated with nosocomial infection, mainly those occurred in patients hospitalized in ICUs. Many nosocomial outbreaks due to A. baumannii isolates have been reported. The most common sources of infection are derived from respiratory tract, indwelling catheters and wounds. Due to problems in the routine clinical microbiology laboratories in speciation of Acinetobacter species and due to the high conservation of primary and secondary structures within species, rRNA genes (16S, 23S and 5S) are commonly used for bacterial identification several laboratories have investigated the use of PCR to rapidly detect and identify bacterial pathogens. [1, 2, 15] Accurate identification and typing of bacterial isolates are essential, particularly when determining strains involved in hospital outbreaks. The genome of the A. baumannii isolates is made of a single circular chromosome, accompanied by two plasmids, however the number of plasmids differ depending on the strain. [16] The whole genome size is about 3,976,747 base pairs in which 3454 are used for protein coding. [17] The GC-content of the three sequences is around 40%, a value corresponding to that reported for other members of the Acinetobacter genus. A. baumannii has several genes that permit it to pick up foreign DNA from its environment, as well as other microbes and incorporate it into its genome. [18] In our study, we attempted to use ITS sequences in order to obtain information about the variation occurring among A. baumannii subspecies and strains. When one ITS amplicon was found in all of the subspecies and strains analyzed, the nucleotide sequences showed similarity percentages higher than 98%. This means that the main intraspecies evolutionary divergence is due to the rearrangement of sequence blocks shared by all of the strains rather than to the accumulation of mutations, which would generate strain-specific sequence blocks. It has been proposed that sequence similarity must be below 95% to qualify as evidence of a novel species, suggesting that the new isolate may be another strain of A. baumannii. [19] 
Conclusion
The rapid and accurate identification of clinically significant Acinetobacter strains by molecular tools will improve insight into their epidemiology and allow for targeted therapeutic and infection control measures against clinically important strains. 
